Demand for abortion pills may rise if Roe v. Wade is overturned. While COVID-19 boosted telemedicine access to the pills, experts believe those loosened regulations may not last long. (Reuters)

PillPack, Amazon’s online pharmacy, has reached a settlement with the U.S. government over allegations that it overcharged Medicare and Medicaid for insulin. PillPack agreed to pay $5.6 million to the federal government and $175,000 to other states. (Endpoints News)

CVS Health saw its first quarter sales increase by 11%. The surge was largely driven by COVID-19 vaccinations and demand for at-home tests during the Omicron surge. (The Wall Street Journal)

The pullback on abortion rights could be widespread if the Supreme Court overturns Roe v. Wade. Some 23 states have abortion bans or trigger laws that would restrict access to abortions. (Politico)

Obesity is reaching “epidemic proportions” in Europe, according to the World Health Organization. 59% of adults are overweight or obese across the continent, a study found. (The Guardian)